Entering text into the input field will update the search result below

Novo Nordisk A/S (NVO) CEO Lars Jorgensen on Q2 2021 Results - Earnings Call Transcript

Aug. 05, 2021 2:35 PM ETNovo Nordisk A/S (NVO) Stock, NONOF Stock
SA Transcripts profile picture
SA Transcripts

Novo Nordisk A/S (NVO) Q2 2021 Earnings Conference Call August 4, 2021 1:00 PM ET

Company Participants

Lars Fruergaard Jørgensen - President & Chief Executive Officer

Karsten Munk Knudsen - Chief Financial Officer

Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corporate Affair

Doug Langa - Executive Vice President & Head of North America Operations

Martin Holst Lange - Executive Vice President & Head of Development

Conference Call Participants

Emmanuel Papadakis - Deutsche Bank

Matthew Weston - Credit Suisse

Wimal Kapadia - Bernstein

Steve Scala - Cowen

Peter Verdult - Citi

Martin Parkhøi - Danske Bank

Carsten Madsen - SEB

Michael Novod - Nordea Markets

Sachin Jain - Bank of America

Seamus Fernandez - Guggenheim Securities

Keyur Parekh - Goldman Sachs

Lars Fruergaard Jørgensen

Thank you very much and welcome to this Novo Nordisk Earnings Call for the First Six Months of 2021 and the outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. I'd like to start by thanking you for your scheduling flexibility today as we decided to advance this earnings call as a consequence of our earlier than anticipated release of our results following an upgrade of both sales and operating profit.

With me I have our Chief Financial Officer, Karsten Munk Knudsen; Executive Vice President and Head of Commercial Strategy and Corporate Affair, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; and finally Executive Vice President and Head of Development, Martin Holst Lange. All presenters will be available for the Q&A session.

Today's earnings release and the slides for this call are available on our website novonordisk.com. Please note that this call is being webcasted live and a recording will be made available on Novo Nordisk's website. The call is scheduled to last for one hour.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About NVO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on NVO

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.